Amgen Inc. (AMGN) Management Presents at Citi's 16th Annual BioPharma Virtual Conference (Transcript)Seeking Alpha • 09/08/21
New Tezepelumab Data Show 86% Reduction In Exacerbations In Patients With Severe Asthma And Comorbid Nasal PolypsPRNewsWire • 09/05/21
Amgen (AMGN) Down 2.2% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 09/02/21
New Data At ESC Congress 2021 Shows Repatha® (evolocumab) Improves Features Of Plaque Stability In Patients With Acute Coronary Syndrome (ACS)PRNewsWire • 08/27/21